| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |